Australian Clinical Labs (ASX:ACL) Change In Receivables : A$0.0 Mil (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Australian Clinical Labs Change In Receivables?

Australian Clinical Labs's change in receivables for the quarter that ended in Dec. 2023 was A$0.0 Mil. It means Australian Clinical Labs's Accounts Receivable stayed the same from Jun. 2023 to Dec. 2023 .

Australian Clinical Labs's change in receivables for the fiscal year that ended in Jun. 2023 was A$0.0 Mil. It means Australian Clinical Labs's Accounts Receivable stayed the same from Jun. 2022 to Jun. 2023 .

Australian Clinical Labs's Accounts Receivable for the quarter that ended in Dec. 2023 was A$74.1 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Australian Clinical Labs's Days Sales Outstanding for the six months ended in Dec. 2023 was 40.05.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Australian Clinical Labs's liquidation value for the six months ended in Dec. 2023 was A$-329.7 Mil.

Australian Clinical Labs Change In Receivables Historical Data

The historical data trend for Australian Clinical Labs's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Australian Clinical Labs Change In Receivables Chart

Australian Clinical Labs Annual Data

Trend

Dec20

Jun21

Jun22

Jun23

Change In Receivables

Australian Clinical Labs Semi-Annual Data
	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Change In Receivables	Get a 7-Day Free Trial			-	-	-	-	-

Australian Clinical Labs Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.0 Mil.

Australian Clinical Labs (ASX:ACL) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Australian Clinical Labs's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	74.138	/	337.816	*	91
=	40.05

2. In Ben Graham's calculation of liquidation value, Australian Clinical Labs's accounts receivable are only considered to be worth 75% of book value:

Australian Clinical Labs's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	24.938	-	418.693	+	0.75 * 74.138	+	0.5 * 16.805
=	-329.7

Australian Clinical Labs Change In Receivables Related Terms

Thank you for viewing the detailed overview of Australian Clinical Labs's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Australian Clinical Labs (ASX:ACL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Australian Clinical Labs Ltd (ASX:ACL) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

1868-1892 Dandenong Road, Clayton, VIC, AUS, 3168

Website

https://www.clinicallabs.com.au

Australian Clinical Labs, or ACL, is Australia's third-largest private pathology provider. ACL earns almost its entire group revenue from pathology services in Australia, which are mostly earned via the publicly funded health Medicare system. ACL is well-established in the states of Western Australia, South Australia, Victoria and the Northern Territory.

Australian Clinical Labs (ASX:ACL) Headlines

No Headlines